MedDataX Logo

Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus

NCT ID: NCT02508220

Last Updated: 2015-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study compares the short-term tinnitus reduction following a single oxytocin intervention with a placebo control condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Tinnitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oxy-Placebo

Syntocinon first, Placebo second 2 puffs in each nostril

Group Type OTHER

Syntocinon

Intervention Type DRUG

Oxytocin nasal spray

Placebo

Intervention Type DRUG

distilled water in nasal spray

Placebo-Oxy

Placebo first, Syntocinon second 2 puffs in each nostril

Group Type OTHER

Syntocinon

Intervention Type DRUG

Oxytocin nasal spray

Placebo

Intervention Type DRUG

distilled water in nasal spray

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Syntocinon

Oxytocin nasal spray

Intervention Type DRUG

Placebo

distilled water in nasal spray

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Oxytocin distilled water

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* chronic tinnitus with a duration \> 6 months
* medical examination by an ENT specialist
* sufficient knowledge of the Portuguese language to follow the instructions and answer the questionnaires
* VAS score \>4 points

Exclusion Criteria

* vascular tinnitus
* muscular tinnitus
* conductive hearing loss
* previous experience with oxytocin nasal spray
* additional medications during the intervention
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Otosul -Otorrinolaringologia Sul-Fluminense

UNKNOWN

Sponsor Role collaborator

Berthold Langguth, MD, Ph.D.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Berthold Langguth, MD, Ph.D.

Chair of the Tinnitus centrum Regensburg

Responsibility Role SPONSOR_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Uni-Reg-Oxy-Tin

Identifier Type: -

Identifier Source: org_study_id